ANNEXON INC. - COMMON STOCK

Annexon Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results with Recent Business Highlights

25 мар 2021 07:00:01 Источник Nasdaq GlobeNewswire

Annexon Advances Classical Complement Platform with Initiation of Global Phase 2 ARCHER Trial in Patients with Geographic Atrophy

01 мар 2021 07:00:00 Источник Nasdaq GlobeNewswire

Annexon Welcomes William H. Carson, M.D. to the Board of Directors

08 фев 2021 07:00:00 Источник Nasdaq GlobeNewswire

Annexon Highlights Recent Achievements and Outlines Expected Key Milestones in 2021 for Its Broad Portfolio of Complement Therapeutics

12 янв 2021 07:00:00 Источник Nasdaq GlobeNewswire

Annexon to Present at the J.P. Morgan 39th Annual Healthcare Conference

05 янв 2021 07:00:01 Источник Nasdaq GlobeNewswire